FBIO Stock Analysis: Buy, Sell, or Hold?
FBIO - Fortress Biotech, Inc.
$3.16
0.08 (2.60%)
▲
5d:
+10.49%
30d:
+13.67%
90d:
+6.04%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When FBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: FBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: FBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.60
Based on -37.5% avg growth
INTRINSIC VALUE TODAY
$0.37
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FBIO is currently trading at $3.16, which is considered extended relative to its 30-day fair value range of $2.59 to $2.96. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.3) compared to its historical average (157.0). Remarkably, the market is currently pricing in an annual earnings decline of 65.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, FBIO is in a strong downtrend. The price is approaching resistance at $3.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: FBIO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+248.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FBIO is in a strong downtrend. The price is approaching resistance at $3.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: FBIO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+248.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.59 -
$2.96
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range (+6.8% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 248.1% below Wall St target ($11.00)
Trading Range Analysis
30-Day Trading Range
$2.59 -
$2.96
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.53
Resistance Level
$3.00
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.26
Wall Street Target
$11.00
(+248.1%)
Revenue Growth (YoY)
22.1%
Profit Margin
193.1%
Valuation Discount vs History
-65.8% cheaper
PE vs Historical
6.3 vs 157.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-65.8%
(market-implied from PE analysis)
1-Year Target
$2.84
(-10%)
2-Year Target
$2.56
(-19%)
3-Year Target
$2.30
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→157)
$57.80
(+1729%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -79.0%)
$8.02
(+154%)
Base:
(SPY PE: 6.3, Growth: -79.0%)
$2.30
(-27%)
Bear:
(PE: 5.3, Growth: -79.0%)
$1.96
(-38%)
📈
Valuation based on Current Earnings
Trailing PE: 0.98 | Current EPS (TTM): $3.23
Bull Case
$1.75
(-45%)
Analyst growth -50.0%, PE expands to 1.1
Base Case
$1.59
(-50%)
Market implied -50.0%, PE stable at 1.0
Bear Case
$2.16
(-32%)
Severe decline -20.0%, PE contracts to 0.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.3 to 157.0
Stabilization Target:
$79.28
(+2409.0%)
PE Expansion Potential:
+2409.0%
Share & Embed Analysis
Last updated: June 24, 2026 7:59 AM ET
Data refreshes hourly during market hours. Next update: 8:59 AM
Data refreshes hourly during market hours. Next update: 8:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 64 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 65 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 59 HOLD |
